Last reviewed · How we verify

NCT06871332

Progressive Relaxation Exercise on Pain, Anxiety and Patient Satisfaction

Completed NA Last updated 11 March 2025
What this trial tests

NA trial testing Progressive relaxation exercise group in Effect of Progressive Relaxation Exercise in 70 participants. Completed in 5 April 2024.

Timeline
2 August 2023
Primary endpoint
5 April 2024
5 April 2024

Quick facts

Lead sponsorTC Erciyes University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment70
Start date2 August 2023
Primary completion5 April 2024
Estimated completion5 April 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

TC Erciyes University

Who can join

18 and older, any sex, with Effect of Progressive Relaxation Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-center, prospective, randomized controlled trial was completed with a total of 70 patients, 35 in each of the intervention and control groups. Data were collected using the Patient Information Form, Visual Analogy Scale and State-Trait Anxiety Inventory. Patients in the intervention group performed progressive relaxation exercise for 20 minutes before femoral sheath removal. The patients in the control group received the standard practice of the clinic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Progressive relaxation exercise group

Trials testing the same drug.

Other TC Erciyes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871332.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing